Year: 2024
Type: article
Abstract: This Viewpoint discusses potential benefits and obstacles regarding US Food and Drug Administration (FDA) oversight of laboratory-developed tests.
Source: JAMA Health Forum
Authors: Daniel G. Aaron, Eli Y. Adashi, I. Glenn Cohen
Institutions: University of Utah, Brown University, Harvard University
Language: English
Topic: Healthcare Regulation
Subfield: Health Information Management
Field: Health Professions
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $5,000
OpenAlex ID: W4403333771